CDC-RFA-TS19-19010301SUPP21.pdf

Centers for Disease Control and Prevention

AGENCY FOR TOXIC SUBSTANCES AND DISEASE REGISTRY

Pediatric Environmental Health Specialty Unit (PEHSU): Expansion Supplement

CDC-RFA-TS19-19010301SUPP21

08/15/2021

Table of Contents Section I. Funding Opportunity Description

Section II. Award Information

Section III. Eligibility Information

Section IV. Application and Submission Information

Section V. Application Review Information

Section VI. Award Administration Information

Section VII. Agency Contacts

Section VIII. Other Information

Part 1. Overview Information Federal Agency Name:

Agency for Toxic Substances and Disease Registry (ATSDR) Notice of Funding Opportunity (NOFO) Title:

Pediatric Environmental Health Specialty Unit (PEHSU): Expansion Supplement Announcement Type:

New - Type 1

Agency Notice of Funding Opportunity Number:

CDC-RFA-TS19-19010301SUPP21

Assistance Listings Number:

93.161 Key Dates:

Due Date for Applications 08/07/2021

08/15/2021 Application must be successfully submitted to Grants.gov by 11:59 pm Eastern Standard Time on the deadline date.

Additional Overview Content:

Executive Summary The Agency for Toxic Substances and Disease Registry (ATSDR) has a mandate to prevent or reduce illness and negative environmental health risks associated with exposure to hazardous substances in the environment. This can best be accomplished by preventing environmental contamination and the potential for exposures. Therefore, educating communities about environmental risk and how to reduce those risks will help to lower negative health outcomes.

Further, preparing primary care clinicians to recognize environmental exposure risks, provide risk reduction screening and/or counseling, and deliver patient care to those at risk of or harm from acute or chronic exposures to hazardous substances in the environment supports ATSDR’s mandate. It will also build health care capacity to assess patient and family environmental exposure risks and reinforce community risk reduction education, and, if needed, aid clinicians to intervene on illness resulting from exposure to hazardous substances in the environment.

Measurable outcomes of the program will be in alignment with one (or more) of the following performance goal(s) for the AGENCY FOR TOXIC SUBSTANCES AND DISEASE

REGISTRY

GPRA goal(s)

1. Reduce the average cost per site to deliver public health findings and recommendations to the public.

2. Advance understanding of the relationship between human exposures to hazardous substances and adverse health effects by completing toxicological profiles for substances hazardous to human health

3. Reduce exposures to toxic substances and mitigate the likelihood of future toxic exposures by increasing EPA's, state regulatory agencies', or private industries' acceptance of ATSDR's recommendations at sites with documented exposures.

4. Protect human health by preventing or mitigating human exposures to toxic substances or related health effects at sites with documented exposures.

This announcement is only for non-research activities supported by CDC. If research is proposed, the application will not be considered. For this purpose, research is defined at https://www.govregs.com/regulations/title42_chapterI_part2_subpartD_section2.52. Guidance on how CDC interprets the definition of research in the context of public health can be found at https://www.hhs.gov/ohrp/regulations-and-policy/regulations/45-cfr-46/index.html (See section 45 CFR 46.102(d)).

Section I. Funding Opportunity Description Statutory Authority This program is authorized under sections 104(i)(14) of the Comprehensive Environmental Response, Compensation, and Liability Act (CERCLA) of 1980, as amended by the Superfund Amendments and Reauthorization Act (SARA) of 1986 [42 U.S.C.§9604(i)(14)]

Background ATSDR, through its Environmental Medicine & Health Systems Intervention Section, proposes to maintain and strengthen the Pediatric Environmental Health Specialty Unit (PEHSU) network in its role as a leading national source of medical information and consultative advice on environmental conditions that influence human health throughout the vulnerable stages of reproduction and pediatric development.

The primary purpose of this notice of funding opportunity (NOFO) intends to build upon established PEHSU capabilities and to reaffirm and strengthen collaboration between ATSDR, Environmental Protection Agency (EPA), and the PEHSU National Program Office (NPO) recipient that will lead and manage day-to-day operations of the national PEHSU network. The recipient will work collaboratively with each regional PEHSU to strengthen effectiveness of the PEHSU network, meet program goals, and achieve targeted health outcomes.

In addition, this NOFO has two (2) required components.

https://www.govregs.com/regulations/title42_chapterI_part2_subpartD_section2.52 https://www.hhs.gov/ohrp/regulations-and-policy/regulations/45-cfr-46/index.html

Component 1: Building capacity among health professionals and environmental justice (EJ)/disadvantaged communities to address children's environmental health risks associated with

COVID-19.

Component 2: Developing educational materials on per- and poly-fluoroalkyl substances (PFAS) for health care professionals in practice and in training to increase awareness of potential health impacts of PFAS, and to increase providers’ capacity to provide risk mitigation guidance to patients and improved clinical care of environmentally exposed individuals.

Each component will be described in detail in Section 2. CDC Project Description.

Purpose The purpose of the program is to build upon established PEHSU capabilities and to reaffirm and strengthen collaboration between ATSDR, Environmental Protection Agency (EPA), and the PEHSU NPO recipient that will lead and manage day-to-day operations of the national PEHSU network. This program addresses the “Healthy People 2030” Objectives:

Community

• ECBP-D07: Increase the number of community organizations that provide prevention services

Schools

• ECBP-D08: Increase interprofessional prevention education in health professions training programs

• ECBP-D09: Increase core clinical prevention and population health education in medical schools

• ECBP-D10: Increase core clinical prevention and population health education in nursing schools

• ECBP-D11: Increase core clinical prevention and population health education in physician assistant training programs

Environmental Health

• EH-08: Reduce exposure to lead

• EH-05: Reduce health and environmental risks from hazardous sites

Neighborhood and Built Environment

• EH-D01: Increase the proportion of schools with policies and practices that promote health and safety

These objectives are available at: https://health.gov/healthypeople

Program Implementation Recipient Activities The recipient, as the PEHSU NPO manager, is encouraged to apply principles of “servant leadership” in the operations and relationship the NPO builds with regional PEHSU personnel. The work plan should build upon the activities presented below for the NPO and regional PEHSUs to undertake. Applicants preparing the work plan are encouraged to provide https://health.gov/healthypeople their contextual view of how they will perform each responsibility outlined including the synergy between NPO responsibilities. The work plan should provide sufficient detail for a reviewer to understand how the recipient organizational capacity and applicant will meet these expectations.

Component 1: This Component is focused on building capacity in EJ/disadvantaged communities to address children’s environmental health risks associated with COVID-19.

Specific tasks to achieve the objectives and outcomes of this Component may vary, but the recipient should focus efforts in the following three Activities. The recipient should create a library of best practices/resources based on the PEHSUs’ accomplishments accessible to entire network and ATSDR. The recipient should also identify and recruit regional PEHSU staff needed to conduct these activities.

a: Targeted environmental medicine education Identify EJ/disadvantaged communities in each PEHSU region that are exposed to environmental hazard(s) that may lead to adverse health outcomes with COVID-19 (e.g., exposure to poor indoor/outdoor air quality from PM2.5, cleaners, disinfectants and other exposures) and provide targeted education on hazard(s) to practicing medical providers in those communities as well as to students in minority serving schools of nursing and medicine (includes Tribal Colleges and Universities, Native American-Serving Non-Tribal Institutions, Alaska Native-Serving Institutions; Asian American Native American Pacific Islander-Serving Institution (AANAPISI);

HBCU & Predominantly Black Institutions, Hispanic Serving Institutions, and Native Hawaiian- Serving Institutions).

Outcome Measures:

Number and demographics of health professionals educated Number of minority-serving medical and nursing schools that:

o incorporate supplemental environmental health content o add environmental health course(s), and/or o implement new curriculum inclusive of environmental health for clinicians

Number of EJ/disadvantaged communities in which education is delivered b: Home visits Increase capacity of PEHSU regions to perform virtual home visits to assess for environmental hazards through health professionals in training, nurses, and Community Health Workers/Promotoras in EJ/disadvantaged communities.

Outcome Measures:

Number of home visits completed, including the type of environmental hazards encountered at each

Number of EJ/disadvantaged communities in which home visits are conducted c: Community outreach Engage with Community Health Workers/Promotoras and other partner organizations to conduct community outreach in EJ/disadvantaged communities to emphasize importance of routine screening (e.g., lead screening) and continued regular health care during the pandemic and beyond.

Outcome Measures:

Number of Community Health Workers/Promotoras and other partner organizations with whom community outreach activities are conducted

Demographics of communities served by outreach activities Number and type of community outreach activities conducted Number of EJ/disadvantaged communities in which outreach activities occur

Component 2: This component is focused on increasing awareness among health professionals in practice and in training of potential health impacts of PFAS. Additionally, activities proposed under this Component should increase healthcare providers’ capacity to provide risk mitigation guidance to patients and improved clinical care to environmentally exposed individuals. The recipient should demonstrate their ability to conduct the following three (3) activities in pursuit of the overall objectives of this Component. The recipient should identify and recruit regional PEHSU staff needed to conduct these activities.

a: PFAS symposium

• Develop a half-day educational session on PFAS that can be conducted as a pre-meeting symposium before large medical organization audiences (examples include American Academy of Pediatrics; Endocrine Society; American College of Obstetricians and Gynecologists;

American Academy of Family Physicians; Association of Women’s Health, Obstetric and Neonatal Nurses; and others). This program can be adapted on a yearly or biyearly basis to address emerging science on PFAS or other environmental exposures.

• Provide CE credit to create incentive for providers to participate.

• Track number of health professionals who attend the symposium and who claim CE credit.

Outcome measures:

Number of medical organizations hosting a PFAS symposium Number of PFAS symposia delivered Number of health professionals attending symposium Number of CE credits claimed by type of health professional b: PFAS Extension for Community Healthcare Outcomes (ECHO)

• Develop ECHO program on PFAS for health care professionals

• Implement training of health care professionals in all 10 PEHSU regions, targeting providers in PFAS-exposed communities.

• Provide Maintenance of Certification (MOC) credits through the American Board of Pediatrics to create incentive for providers to participate.

• Track number of health professionals who participate in the program and who claim MOC credit.

Outcome measures:

Number of PFAS ECHO programs delivered Number of health professionals who participate in programs, by type of professional

Number of MOC credits claimed c: PFAS Educational Material

• Develop a clinical overview of what is currently known about PFAS and potential health effects.

• Publish in format that is accessible to practicing health care professionals (e.g., Up to Date, which can be linked to electronic health records for access during patient visits; or high impact journal)

• Track number of health professionals who use the material and track CE claimed (if applicable).

Outcome measures:

Completion of clinical review of PFAS Plan for delivering material in clinical encounters

Other Activities If other major activities not specified in the NOFO are deemed as necessary to accomplish the below NOFO expectations.

CDC Activities ATSDR activities for this program are as follows:

•Provide technical assistance in identifying collaborative opportunities available through federal programs that align with the PEHSU Program goals and objectives.

•Provide technical assistance in identifying needs for pediatric and reproductive environmental health education targeting health care providers, environmental health professionals, families, teachers, and the public.

•Provide information, instructional resources, technical assistance and collaboration support needed to effectively work with health care providers, environmental health professionals, families, and the public to improve understanding of health effects of known and emerging contaminants of concern.

•Assist in the development of evaluation plans that examine program effectiveness and identifies outcomes of the PEHSU Program.

•Provide assistance in establishing communication and resource networks that include partners such as other Federal agencies, State and local health departments, tribal governments, environmental and health professionals, non-governmental organizations, and academic, medical centers, and clinical associations.

Funding Strategy This announcement contains two components that will be funded from separate funding sources.

The applicant must submit proposed activities for both Components. Successful applicants will receive funding under both Components.

Section II. Award Information Type of Award:

CA (Cooperative Agreement) CDC substantial involvement in this program appears in the Activities Section above.

Award Mechanism:

U61 Preventive Health Activities Regarding Hazardous Substances

Fiscal Year Funds:

Approximate Total Supplemental Funding:

$ 3,500,000 This amount is subject to availability of funds. Includes direct and indirect costs.

Approximate funding:

Component 1: $2,500,000 Component 2: $1,000,000

Approximate Number of Awards:

Approximate Average Award:

$ 3,500,000 This amount is for the budget period only and includes direct costs and indirect costs as applicable.

Floor of Individual Award Range:

$ 0 Ceiling of Individual Award Range:

$ 3,500,000 This ceiling is for a 12-month budget period.

Anticipated Award Date:

September 01, 2021

Budget Period Length:

12 month(s)

Period of Performance Length:

1 year(s)

If you are successful and receive a Notice of Award, in accepting the award, you agree that the award and any activities thereunder are subject to all provisions of 45 CFR Part 75, currently in effect or implemented during the period of the award, other Department regulations and policies in effect at the time of the award, and applicable statutory provisions.

Section III. Eligibility Information

Eligible Applicants The following recipients may submit an application:

Eligibility Category:

25 (Others (see text field entitled "Additional Information on Eligibility" for clarification))

Additional Information on Eligibility Eligible applicant: American Academy of Pediatrics (AAP)

Required Registrations System for Award Management and Universal Identifier Requirements An organization must be registered at the three following locations before it can submit an application for funding at www.grants.gov.

a. Data Universal Numbering System: All applicant organizations must obtain a Data Universal Numbering System (DUNS) number. A DUNS number is a unique nine-digit identification number provided by Dun & Bradstreet (D&B). It will be used as the Universal Identifier when applying for federal awards or cooperative agreements. The applicant organization may request a DUNS number by telephone at 1-866-705-5711 (toll free) or Internet at http://fedgov.dnb.com/webform/displayHomePage.do. The DUNS number will be provided at no charge. If funds are awarded to an applicant organization that includes sub-recipients, those sub-recipients must provide their DUNS numbers before accepting any funds.

b. System for Award Management (SAM): The SAM is the primary registrant database for the federal government and the repository into which an entity must submit information required to conduct business as a recipient. All applicant organizations must register with SAM, and will be assigned a SAM number. All information relevant to the SAM number must be current at all times during which the applicant has an application under consideration for funding by CDC. If an award is made, the SAM information must be maintained until a final financial report is submitted or the final payment is received, whichever is later. The SAM registration process usually requires not more than five business days, and registration must be renewed annually.

Additional information about registration procedures may be found at SAM.gov.

c. Grants.gov: The first step in submitting an application online is registering your organization through www.grants.gov, the official HHS E-grant website. Registration information is located at the "Applicant Registration" option at www.grants.gov. All applicant organizations must register with www.grants.gov. The one-time registration process usually takes not more than five days to complete. Applicants must start the registration process as early as possible.

Cost Sharing or Matching Cost Sharing / Matching Requirement:

No Other Special Requirements https://www.grants.gov/ http://fedgov.dnb.com/webform/displayHomePage.do https://sam.gov/content/home https://www.grants.gov/ http://www.grants.gov/ https://www.grants.gov/

Note: Title 2 of the United States Code Section 1611 states that an organization described in Section 501(c)(4) of the Internal Revenue Code that engages in lobbying activities is not eligible to receive Federal funds constituting a grant, loan, or an award.

Maintenance of Effort Maintenance of Effort is not required for this program

Section IV. Application and Submission Information Address to Request Application Package Applicants must download the application package associated with this funding opportunity from Grants.gov.

If the applicant encounters technical difficulties with Grants.gov, the applicant should contact Grants.gov Customer Service. The Grants.gov Contact Center is available 24 hours a day, 7 days a week, with the exception of all Federal Holidays. The Contact Center provides customer service to the applicant community. The extended hours will provide applicants support around the clock, ensuring the best possible customer service is received any time it is needed. You can reach the Grants.gov Support Center at 1-800-518-4726 or by email at support@grants.gov. Submissions sent by email, fax, CD’s or thumb drives of applications will not be accepted.

Content and Form of Application Submission Unless specifically indicated, this announcement requires submission of the following information:

Project Abstract A Project Abstract must be completed in the Grants.gov application forms. The Project Abstract must contain a summary of the proposed activity suitable for dissemination to the public. It should be a self-contained description of the project and should contain a statement of objectives and methods to be employed. It should be informative to other persons working in the same or related fields and insofar as possible understandable to a technically literate lay reader. This abstract must not include any proprietary/confidential information.

Project Narrative A Project Narrative must be submitted with the application forms. The project narrative must be uploaded in a PDF file format when submitting via Grants.gov. The narrative must be submitted in the following format:

30: Maximum number of pages Font size: 12 point unreduced, Times New Roman Double spaced Page margin size: One inch Number of all narrative pages; not to exceed the maximum number of pages.

The narrative should address activities to be conducted over the entire Period of Performance and must include the following items in the order listed.

mailto:support@grants.gov

Additional information may be included in the application appendices. The appendices must be uploaded to the "Other Attachments Form" of application package in Grants.gov. Note:

appendices will not be counted toward the narrative page limit. This additional information includes:

Additional information submitted via Grants.gov must be uploaded in a PDF file format, and should be named:

_________: Maximum number of allowable electronic attachments

Submission Dates and Times This announcement is the definitive guide on application content, submission, and deadline. It supersedes information provided in the application instructions. If the application submission does not meet the deadline published herein, it will not be eligible for review and the recipient will be notified the application did not meet the submission requirements.

This section provides applicants with submission dates and times. Applications that are submitted after the deadlines will not be processed.

If Grants.gov is inoperable and cannot receive applications, and circumstances preclude advance notification of an extension, then applications must be submitted by the first business day on which grants.gov operations resume.

Application Deadline Date

Number Of Days from Publication 60

08/15/2021 Explanation of Deadlines: Application must be successfully submitted to Grants.gov by 11:59 pm Eastern Standard Time on the deadline date.

Pilot Program for Enhancement of Employee Whistleblower Protections All applicants will be subject to a term and condition that applies the terms of 48 CFR section

3.908 to the award and requires that recipients inform their employees in writing (in the predominant native language of the workforce) of employee whistleblower rights and protections under 41 U.S.C 4712.

Copyright Interest Provisions This provision is intended to ensure that the public has access to the results and accomplishments of public health activities funded by CDC. Pursuant to applicable grant regulations and CDC’s Public Access Policy, Recipient agrees to submit into the National Institutes of Health (NIH) Manuscript Submission (NIHMS) system an electronic version of the final, peer-reviewed manuscript of any such work developed under this award upon acceptance for publication, to be made publicly available no later than 12 months after the official date of publication. Also at the time of submission, Recipient and/or the Recipient’s submitting author must specify the date the final manuscript will be publicly accessible through PubMed Central (PMC). Recipient and/or Recipient’s submitting author must also post the manuscript through PMC within twelve (12) months of the publisher's official date of final publication; however the author is strongly encouraged to make the subject manuscript available as soon as possible. The recipient must obtain prior approval from the CDC for any exception to this provision.

The author's final, peer-reviewed manuscript is defined as the final version accepted for journal publication, and includes all modifications from the publishing peer review process, and all graphics and supplemental material associated with the article. Recipient and its submitting authors working under this award are responsible for ensuring that any publishing or copyright agreements concerning submitted articles reserve adequate right to fully comply with this provision and the license reserved by CDC. The manuscript will be hosted in both PMC and the CDC Stacks institutional repository system. In progress reports for this award, recipient must identify publications subject to the CDC Public Access Policy by using the applicable NIHMS identification number for up to three (3) months after the publication date and the PubMed Central identification number (PMCID) thereafter.

Federal Funding Accountability and Transparency Act of 2006 (FFATA), P.L. 109–282, as amended by section 6202 of P.L. 110–252 requires full disclosure of all entities and organizations receiving Federal funds including awards, contracts, loans, other assistance, and payments through a single publicly accessible Web site, www.USASpending.gov.

Compliance with this law is primarily the responsibility of the Federal agency. However, two elements of the law require information to be collected and reported by applicants: 1) information on executive compensation when not already reported through the SAM, and 2) similar information on all sub-awards/subcontracts/consortiums over $25,000.

For the full text of the requirements under the FFATA and HHS guidelines, go to:

https://www.gpo.gov/fdsys/pkg/PLAW-109publ282/pdf/PLAW-109publ282.pdf, https://www.fsrs.gov/documents/ffata_legislation_110_252.pdf http://www.hhs.gov/grants/grants/grants-policies-regulations/index.html#FFATA.

Funding Restrictions Funding Restrictions:

Restrictions, which must be taken into account while writing the budget, are as follows:

Recipients may not use funds for research.

Recipients may not use funds for clinical care.

Recipients may only expend funds for reasonable program purposes, including personnel, travel, supplies, and services, such as contractual.

Recipients may not generally use HHS/CDC/ATSDR funding for the purchase of furniture or equipment. Any such proposed spending must be identified in the budget.

The direct and primary recipient in a cooperative agreement program must perform a substantial role in carrying out project objectives and not merely serve as a conduit for an award to another party or provider who is ineligible.

Other than for normal and recognized executive-legislative relationships, no funds may be used for: publicity or propaganda purposes, for the preparation, distribution, or use of any material designed to support or defeat the enactment of legislation before any legislative body the salary or expenses of any grant or contract recipient, or agent acting for such recipient, related to any http://www.usaspending.gov/ https://www.gpo.gov/fdsys/pkg/PLAW-109publ282/pdf/PLAW-109publ282.pdf, https://www.fsrs.gov/documents/ffata_legislation_110_252.pdf http://www.hhs.gov/grants/grants/grants-policies-regulations/index.html#FFATA.

activity designed to influence the enactment of legislation, appropriations, regulation, administrative action, or Executive order proposed or pending before any legislative body.

See Additional Requirement (AR) 12 for detailed guidance on this prohibition and additional guidance on lobbying for CDC recipients.

The recipient can obtain guidance for completing a detailed justified budget on the CDC website, at the following Internet address: http://www.cdc.gov/grants/interestedinapplying/applicationprocess.html

Other Submission Requirements Application Submission Submit the application electronically by using the forms and instructions posted for this funding opportunity on www.Grants.gov.

Note: Application submission is not concluded until successful completion of the validation process. After submission of your application package, recipients will receive a "submission receipt" email generated by Grants.gov. Grants.gov will then generate a second e-mail message to recipients which will either validate or reject their submitted application package.

This validation process may take as long as two (2) business days. Recipients are strongly encouraged check the status of their application to ensure submission of their application package is complete and no submission errors exists. To guarantee that you comply with the application deadline published in the Notice of Funding Opportunity, recipients are also strongly encouraged to allocate additional days prior to the published deadline to file their application. Non-validated applications will not be accepted after the published application deadline date.

In the event that you do not receive a ''validation'' email within two (2) business days of application submission, please contact Grants.gov. Refer to the email message generated at the time of application submission for instructions on how to track your application or the Application User Guide, Version 3.0 page 57.

Electronic Submission of Application:

Applications must be submitted electronically by using the forms and instructions posted for this notice of funding opportunity at www.grants.gov. Applicants can complete the application package using Workspace, which allows forms to be filled out online or offline. All application attachments must be submitted using a PDF file format. Instructions and training for using Workspace can be found at www.grants.gov under the "Workspace Overview" option.

Applications submitted through www.Grants.gov, are electronically time/date stamped and assigned a tracking number. The Authorized Organizational Representative (AOR) will receive an e-mail notice of receipt when HHS/CDC receives the application. The tracking number serves to document submission and initiate the electronic validation process before the application is made available to CDC for processing.

If the recipient encounters technical difficulties with Grants.gov, the recipient should contact Grants.gov Customer Service. The Grants.gov Contact Center is available 24 hours a day, 7 days a week. The Contact Center provides customer service to the recipient community. The extended http://www.cdc.gov/grants/additionalrequirements/index.html http://www.cdc.gov/grants/additionalrequirements/index.html http://www.cdc.gov/grants/additionalrequirements/index.html http://www.cdc.gov/grants/interestedinapplying/applicationprocess.html hours will provide recipients support around the clock, ensuring the best possible customer service is received any time it’s needed. You can reach the Grants.gov Support Center at 1-800- 518-4726 or by email at support@grants.gov. Submissions sent by e-mail, fax, CD’s or thumb drives of applications will not be accepted.

After consulting with the Grants.gov Support Center, if the technical difficulties remain unresolved and electronic submission is not possible to meet the established deadline, organizations may submit a request prior to the application deadline by email to the Grants Management Specialist/Officer for permission to submit a paper application. An organization's request for permission must: (a) include the Grants.gov case number assigned to the inquiry, (b) describe the difficulties that prevent electronic submission and the efforts taken with the Grants.gov Support Center (c) be submitted to the Grants Management Specialist/Officer at least 3 calendar days prior to the application deadline. Paper applications submitted without prior approval will not be considered.

Section V. Application Review Information Eligible recipients are required to provide measures of effectiveness that will demonstrate the accomplishment of the various identified objectives of the CDC-RFA-TS19-19010301SUPP21 Measures of effectiveness must relate to the performance goals stated in the "Purpose" section of this announcement. Measures of effectiveness must be objective, quantitative and measure the intended outcome of the proposed program. The measures of effectiveness must be included in the application and will be an element of the evaluation of the submitted application.

Criteria Eligible recipients will be evaluated against the following criteria:

Approach Maximum Points: 0 The extent to which the applicant:

1. Describes the overall strategy for accomplishing the objectives of the project.

2. Provides a workplan with strategies, activities, and performance measures that align to specific program outcomes.

3. Describes an organized approach to implementing the strategies and activities listed in the Purpose section of the NOFO.

Budget Maximum Points: 0 The extent to which the applicant:

1. Proposes a budget appropriate for the planned activities.

2. Provides a detailed/itemized budget and narrative consistent with the stated activities and performance measures.

3. Provides budget details on proposed contractors/consultants to include work plan, period of performance, and unit cost.

Organizational Capacity to Implement Activities Maximum Points: 0 The extent to which the applicant:

1. indicates expertise, experience, and capacity to efficiently and effectively assess and address the technical assistance needs of stakeholders.

mailto:support@grants.gov

2. demonstrates the appropriate existing infrastructure and skill sets necessary to carry out the proposed activities.

Review and Selection Process Review Eligible applications will be jointly reviewed for responsiveness by AGENCY FOR TOXIC SUBSTANCES AND DISEASE REGISTRY and Office of Grants Services (OGS). Incomplete applications and applications that are non-responsive will not advance through the review process. Recipients will be notified in writing of the results.

An objective review panel will evaluate complete and responsive applications according to the criteria listed in Section V. Application Review Information, subsection entitled "Criteria".

Selection CDC will provide justification for any decision to fund out of rank order.

Anticipated Announcement and Award Dates Section VI. Award Administration Information Award Notices Successful recipients will receive a Notice of Award (NoA) from the CDC Office of Grants Services. The NoA shall be the only binding, authorizing document between the recipient and CDC. The NoA will be signed by an authorized Grants Management Officer and e-mailed to the program director. A hard copy of the NoA will be mailed to the recipient fiscal officer identified in the application.

Unsuccessful recipients will receive notification of the results of the application review by mail.

Administrative and National Policy Requirements Administrative and National Policy Requirements, Additional Requirements (ARs) outline the administrative requirements found in 45 CFR Part 75 and the HHS Grants Policy Statement and other requirements as mandated by statute or CDC policy. CDC programs must indicate which ARs are relevant to the NOFO. Recipients must then comply with the ARs listed in the NOFO.

Do not include any ARs that do not apply to this NOFO. NOFO Recipients must comply with administrative and national policy requirements as appropriate. For more information on the Code of Federal Regulations, visit the National Archives and Records Administration: https://www.archives.gov/federal-register/cfr. For competing supplements, ARs remain in effect as published in the original announcement.

Continuing Continuations - AR-19: Third Party Agreements – ATSDR (AR-19) AR-37: Prohibition on certain telecommunications and video surveillance services or equipment for all awards issued on or after August 13, 2020

The full text of the Uniform Administrative Requirements, Cost Principles, and Audit Requirements for HHS Awards, 45 CFR 75, can be found at:

https://www.ecfr.gov/cgi-bin/text-idx?node=pt45.1.75 https://www.archives.gov/federal-register/cfr http://www.cdc.gov/grants/additionalrequirements/index.html https://www.cdc.gov/grants/additional-requirements/ar-37.html https://www.cdc.gov/grants/additional-requirements/ar-37.html https://www.ecfr.gov/cgi-bin/text-idx?node=pt45.1.75

Reporting Federal Funding Accountability and Transparency Act of 2006 (FFATA), P.L. 109–282, as amended by section 6202 of P.L. 110–252 requires full disclosure of all entities and organizations receiving Federal funds including awards, contracts, loans, other assistance, and payments through a single publicly accessible Web site, http://www.USASpending.gov

Compliance with this law is primarily the responsibility of the Federal agency. However, two elements of the law require information to be collected and reported by applicants: 1) information on executive compensation when not already reported through the SAM, and 2) similar information on all sub-awards/subcontracts/consortiums over $25,000.

For the full text of the requirements under the FFATA and HHS guidelines, go to:

https://www.gpo.gov/fdsys/pkg/PLAW-109publ282/pdf/PLAW-109publ282.pdf, https://www.fsrs.gov /documents /ffata_legislation_ 110_252.pdf http://www.hhs.gov/grants/grants/grants-policies-regulations/index.html#FFATA.

1. The interim progress report is due no less than 120 days before the end of the budget period [you may choose to INSERT a due date rather than use the "no less than" language]. The Interim Progress report will serve as the non-competing continuation applications, and must contain the following elements:

a. Standard Form (“SF”) 424S Form.

b. SF-424A Budget Information-Non-Construction Programs.

c. Budget Narrative.

d. Indirect Cost Rate Agreement.

e. Project Narrative.

Additionally, funded recipients must provide CDC with an original, plus two hard copies of the following reports:

2. Quarterly reports are due within 30 days of the end of each quarter from the beginning of the budget period and should include:

a. Quantitative data including amounts billed for the quarter; cumulative billed for the period;

and remaining projected amounts for the quarter and project period. Information should be provided regarding challenges experienced or anticipated in spending funding.

b. Summary of progress and insights, highlights, and accomplishments covering the recipient activities cited in this NOFO. These reports will also highlight additional accomplishments gained through ongoing partnerships and formalized collaborations. These reports provide the recipient an opportunity to reflect on progress related to annual work plan goals and objectives, describe which objectives have been met, summarize ongoing activities (yet to be met), and then, if needed, propose rationale for work plan modifications.

c. National and regional impact-stories resulting from PEHSU actions, data on performance measurement achievement, and program evaluation planning, methods of assessment and outcome findings. ATSDR will discuss with the recipient the documentation types and format included in the quarterly summary reports.

http://www.usaspending.gov/ https://www.gpo.gov/fdsys/pkg/PLAW-109publ282/pdf/PLAW-109publ282.pdf, https://www.fsrs.gov/documents/ffata_legislation_110_252.pdf http://www.hhs.gov/grants/grants/grants-policies-regulations/index.html#FFATA.

3. Federal Financial Report (FFR)(SF425): (Required) The annual FFR form (SF-425) is required and must be submitted through the Payment Management System (PMS) 90 days after the end of the budget period.

4. The Final Performance Report is due 90 days after the end of the period of performance. The Final FFR is due 90 days after the end of the period of performance and must be submitted through the Payment Management System (PMS).

Termination CDC may impose other enforcement actions in accordance with 45 CFR 75.371- Remedies for Noncompliance, as appropriate.

The Federal award may be terminated in whole or in part as follows:

(1) By the HHS awarding agency or pass-through entity, if the non-Federal entity fails to comply with the terms and conditions of the award;

(2) By the HHS awarding agency or pass-through entity for cause;

(3) By the HHS awarding agency or pass-through entity with the consent of the non-Federal entity, in which case the two parties must agree upon the termination conditions, including the effective date and, in the case of partial termination, the portion to be terminated; or

(4) By the non-Federal entity upon sending to the HHS awarding agency or pass-through entity written notification setting forth the reasons for such termination, the effective date, and, in the case of partial termination, the portion to be terminated. However, if the HHS awarding agency or pass-through entity determines in the case of partial termination that the reduced or modified portion of the Federal award or subaward will not accomplish the purposes for which the Federal award was made, the HHS awarding agency or pass-through entity may terminate the Federal award in its entirety.

Reporting of Foreign Taxes (International/foreign projects only) A. Valued Added Tax (VAT) and Customs Duties – Customs and import duties, consular fees, customs surtax, valued added taxes, and other related charges are hereby authorized as an allowable cost for costs incurred for non-host governmental entities operating where no applicable tax exemption exists. This waiver does not apply to countries where a bilateral agreement (or similar legal document) is already in place providing applicable tax exemptions and it is not applicable to Ministries of Health. Successful applicants will receive information on VAT requirements via their Notice of Award.

B. The U.S. Department of State requires that agencies collect and report information on the amount of taxes assessed, reimbursed and not reimbursed by a foreign government against commodities financed with funds appropriated by the U.S. Department of State, Foreign Operations and Related Programs Appropriations Act (SFOAA) (“United States foreign assistance funds”). Outlined below are the specifics of this requirement:

1) Annual Report: The recipient must submit a report on or before November 16 for each foreign country on the amount of foreign taxes charged, as of September 30 of the same year, by a foreign government on commodity purchase transactions valued at 500 USD or more financed with United States foreign assistance funds under this grant during the prior United States fiscal year (October 1 – September 30), and the amount reimbursed and unreimbursed by the foreign government. [Reports are required even if the recipient did not pay any taxes during the reporting period.]

2) Quarterly Report: The recipient must quarterly submit a report on the amount of foreign taxes charged by a foreign government on commodity purchase transactions valued at 500 USD or more financed with United States foreign assistance funds under this grant. This report shall be submitted no later than two weeks following the end of each quarter: April 15, July 15, October 15 and January 15.

3) Terms: For purposes of this clause:

“Commodity” means any material, article, supplies, goods, or equipment;

“Foreign government” includes any foreign government entity;

“Foreign taxes” means value-added taxes and custom duties assessed by a foreign government on a commodity. It does not include foreign sales taxes.

4) Where: Submit the reports to the Director and Deputy Director of the CDC office in the country(ies) in which you are carrying out the activities associated with this cooperative agreement. In countries where there is no CDC office, send reports to VATreporting@cdc.gov.

5) Contents of Reports: The reports must contain:

a. recipient name;

b. contact name with phone, fax, and e-mail;

c. agreement number(s) if reporting by agreement(s);

d. reporting period;

e. amount of foreign taxes assessed by each foreign government;

f. amount of any foreign taxes reimbursed by each foreign government;

g. amount of foreign taxes unreimbursed by each foreign government.

6) Subagreements. The recipient must include this reporting requirement in all applicable subgrants and other subagreements.

Section VII. Agency Contacts CDC encourages inquiries concerning this announcement.

For programmatic technical assistance and general inquiries, contact:

First Name:

Amanda Last Name:

Cadore Project Officer Department of Health and Human Services Centers for Disease Control and Prevention mailto:VATreporting@cdc.gov.

Street 1:

Street 2:

City:

State:

Zip:

Telephone:

Email:

FZJ3@cdc.gov For financial, grants management, budget assistance and general inquiries, contact:

Address:

First Name:

Julie Last Name:

Davis Grants Management Specialist Department of Health and Human Services Office of Grants Services

Street 1:

Street 2:

City:

State:

Zip:

Telephone:

Email:

XXG6@cdc.gov Section VIII. Other Information Other CDC Notice of Funding Opportunities can be found at www.grants.gov.